FLT3 and acute myeloid leukemia: Here, we observed significant increase of endogenous ROS levels in FLT3-ITD AML cells after treated with IHCH9033, and pretreatment with the ROS scavenger N-Acetylcysteine (NAC) substantially reduced ROS production (Fig. 1e).